Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoflavin in the Complex Rehabilitation of Patients With Acute Stroke
NCT05935787Phase 3Completed
- Sponsor
- POLYSAN
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stroke comparing Cytoflavin with Placebo (2 arms). Primary endpoint: Change of performance at 40 days. Started Jun 2023; status: completed.
02
Drugs
Cytoflavin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT05935787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935787.